openheart.bmj1d
Epidemiology of myocarditis following COVID-19 or influenza and use of diagnostic assessments
Background Previous research has suggested a heightened risk of acute myocarditis after COVID-19 infection. However, it is ...
openheart.bmj9d
Hyperuricaemia elevates risk of short-term readmission and mortality in patients with heart failure
Background Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Serum uric acid (SUA), a product of ...
openheart.bmj12d
Cardiac remodelling in patients with atrial fibrillation and obstructive sleep apnoea
Background Obstructive sleep apnoea (OSA) can cause left atrial (LA) and left ventricular (LV) remodelling, which is linked ...
openheart.bmj12d
Predicting troponin biomarker elevation from electrocardiograms using a deep neural network
Background Elevated troponin levels are a sensitive biomarker for cardiac injury. The quick and reliable prediction of ...
openheart.bmj15d
Prognostic value of multimodality imaging in the contemporary management of cardiac sarcoidosis
Background Echocardiography, cardiac magnetic resonance and cardiac 18 fluorodeoxyglucose positron emission tomography (FDG-PET) imaging play key roles in the diagnosis and management of cardiac ...